Enzymotec is pleased to announce that it has been awarded the prestigious Deloitte Israel Technology Fast 50 award for the 3rd consecutive year. This year Enzymotec rose to number 19 among Israel’s fastest growing technology companies and was the 2nd one in the Biotech/Pharmaceutical/Medical Equipment section.
The Deloitte Technology Fast 50, one of the Israel's foremost technology award programs, is part of the Global Fast 500 program. The Fast 50 ranks the country's 50 fastest-growing technology companies based on five-year revenue growth between over the previous five years as reflected in audited figures. The honor is given in recognition of the companies’ “business growth, technological in novation and entrepreneurial spirit.”
Enzymotec is a dynamic biotech company and a leading global supplier of lipid-based products and solutions. Enzymotec develops, manufactures and markets innovative biofunctional ingredients and final products based on sophisticated proprietary technologies.
Enzymotec's products treat conditions in the largest therapeutic markets and deliver innovative solutions in three business segments:
- Orthomolecular Medicine
Practice of preventing and treating diseases by providing the body with optimal amounts of substances which are natural to the body
- Infant Nutrition
Providing lipid compositions that mimic the fat in human milk for the wellbeing of infants
- Active Pharmaceutical Ingredients (API) & BioFunctional Ingredients (BFI)
Providing ingredients for the pharmaceutical and the dietary supplement markets